These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9952107)

  • 1. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
    Ogami M; Ikura Y; Nishiguchi S; Kuroki T; Ueda M; Sakurai M
    Lab Invest; 1999 Jan; 79(1):15-26. PubMed ID: 9952107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
    Kawakami Y; Kitamoto M; Nakanishi T; Yasui W; Tahara E; Nakayama J; Ishikawa F; Tahara H; Ide T; Kajiyama G
    Oncogene; 2000 Aug; 19(34):3888-93. PubMed ID: 10951582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
    Tahara H; Nakanishi T; Kitamoto M; Nakashio R; Shay JW; Tahara E; Kajiyama G; Ide T
    Cancer Res; 1995 Jul; 55(13):2734-6. PubMed ID: 7796395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
    Harada K; Yasoshima M; Ozaki S; Sanzen T; Nakanuma Y
    J Pathol; 2001 Feb; 193(2):210-7. PubMed ID: 11180168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
    Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
    Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL
    Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
    Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
    Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
    Park YM; Choi JY; Byun BH; Cho CH; Kim HS; Kim BS
    Exp Mol Med; 1998 Mar; 30(1):35-40. PubMed ID: 9873820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of telomerase and its RNA in nasopharyngeal carcinoma].
    Wen Z; Xiao J; Tang F; Tian Y; Zhao S; Chen B
    Chin Med J (Engl); 2000 Jun; 113(6):525-8. PubMed ID: 11775871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
    Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
    Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatitis C virus RNA in the tissue of hepatocellular carcinoma by multiple detection system.
    Li L; Wang W; Yu X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):47-51, 101. PubMed ID: 11503025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma.
    Masutomi K; Kaneko S; Yasukawa M; Arai K; Murakami S; Kobayashi K
    Oncogene; 2002 Aug; 21(38):5946-50. PubMed ID: 12185596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.